Young women usually present with larger tumor size and aggressive tumor biology, with a higher proportion of luminal B, human epidermal growth factor receptor 2 (HER2)-positive, or triple-negative breast cancer (TNBC) [4]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.